Reports
Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The global artificial insemination market stood at a value of USD 2.51 billion in 2020. The industry is further anticipated to grow at a CAGR of about 9% in the forecast period of 2023-2028, owing to the rising number of women being affected by infertility.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Artificial insemination is a primary treatment for infertility as it is minimally invasive and cost effective. It is used in fertility clinics and other facilities, and home. The various types of artificial insemination are:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry can be further bifurcated on the basis of source type into:
The EMR report looks into the regional artificial insemination markets like North America, Latin America, Europe, Middle East and Africa, and Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Intrauterine insemination segment is leading the sector as a result of its high preference in the treatment of infertility. Fertility clinics sector holds the largest market share owing to increase in number of medical centres providing infertility treatments. Europe retained the largest share in the market followed by North America due to decline in fertility rate.
The report presents a detailed analysis of the following key players in the global artificial insemination industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2018-2022 |
Forecast Period | 2023-2028 |
Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Application, Source Type, Region |
Breakup by Type | Intrauterine Insemination, Intracervical Insemination, Intravaginal Insemination, Intratubal Insemination |
Breakup by Application | Fertility Clinics & Other Facilities, Home |
Breakup by Source Type | AIH-Husband, Aid-Donor |
Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
Companies Covered | Vitrolife Inc., Rinovum Women’s Health, Llc, Genea Ltd, Fujifilm Irvine Scientific, Inc., Pride Angel, Rocket Medical Plc, Others |
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Artificial Insemination Market Analysis
8.1 Key Industry Highlights
8.2 Global Artificial Insemination Historical Market (2018-2022)
8.3 Global Artificial Insemination Market Forecast (2023-2028)
8.4 Global Artificial Insemination Market by Type
8.4.1 Intrauterine Insemination
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Intracervical Insemination
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Intravaginal Insemination
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.4.4 Intratubal Insemination
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2018-2022)
8.4.4.3 Forecast Trend (2023-2028)
8.5 Global Artificial Insemination Market by Application
8.5.1 Fertility Clinics and Other Facilities
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Home
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.6 Global Artificial Insemination Market by Source Type
8.6.1 AIH-Husband
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Aid-Donor
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.7 Global Artificial Insemination Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2022)
9.5.2 Forecast Trend (2023-2028)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Vitrolife Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Rinovum Women’s Health, Inc.
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Genea Ltd.
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Fujifilm Irvine Scientific, Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Pride Angel Ltd.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Rocket Medical Plc
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Artificial Insemination Market: Key Industry Highlights, 2018 and 2028
2. Global Artificial Insemination Historical Market: Breakup by Type (USD Million), 2018-2022
3. Global Artificial Insemination Market Forecast: Breakup by Type (USD Million), 2023-2028
4. Global Artificial Insemination Historical Market: Breakup by Application (USD Million), 2018-2022
5. Global Artificial Insemination Market Forecast: Breakup by Application (USD Million), 2023-2028
6. Global Artificial Insemination Historical Market: Breakup by Source Type (USD Million), 2018-2022
7. Global Artificial Insemination Market Forecast: Breakup by Source Type (USD Million), 2023-2028
8. Global Artificial Insemination Historical Market: Breakup by Region (USD Million), 2018-2022
9. Global Artificial Insemination Market Forecast: Breakup by Region (USD Million), 2023-2028
10. North America Artificial Insemination Historical Market: Breakup by Country (USD Million), 2018-2022
11. North America Artificial Insemination Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Europe Artificial Insemination Historical Market: Breakup by Country (USD Million), 2018-2022
13. Europe Artificial Insemination Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Asia Pacific Artificial Insemination Historical Market: Breakup by Country (USD Million), 2018-2022
15. Asia Pacific Artificial Insemination Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Latin America Artificial Insemination Historical Market: Breakup by Country (USD Million), 2018-2022
17. Latin America Artificial Insemination Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Middle East and Africa Artificial Insemination Historical Market: Breakup by Country (USD Million), 2018-2022
19. Middle East and Africa Artificial Insemination Market Forecast: Breakup by Country (USD Million), 2023-2028
20. Global Artificial Insemination Market Structure
In 2020, the global artificial insemination market attained a value of nearly USD 2.51 billion.
The market is projected to grow at a CAGR of 9% between 2023 and 2028.
The major industry driver of the market is rising urbanisation and the rising number of people being affected by infertility.
The key trends in the market are increase in number of medical centres providing infertility treatments.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with Europe accounting for the largest share in the market.
Intrauterine semination is the dominant type in the industry.
The application sectors include fertility clinics and home, among other facilities.
The source types include AIH-Husband and Aid-Donor.
The major players in the industry are Vitrolife Inc., Rinovum Women’s Health, Llc, Genea Ltd, Fujifilm Irvine Scientific, Inc., Pride Angel, Rocket Medical Plc, Others.
The global artificial insemination market attained a value of USD 2.51 billion in 2020, driven by the rising number of people being affected by infertility. Aided by the increase in number of medical centres providing infertility treatments, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 9%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its types, the artificial insemination industry can be segmented into intrauterine insemination, intracervical insemination, intravaginal insemination and intratubal insemination, with intrauterine insemination accounting for the largest market share. The application sectors include fertility clinics and home, among other facilities. The source types include AIH-Husband and Aid-Donor. The major regional markets for artificial insemination are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with Europe accounting for the largest share of the market. The key players in the above market include Vitrolife Inc., Rinovum Women’s Health, Llc, Genea Ltd, Fujifilm Irvine Scientific, Inc., Pride Angel, Rocket Medical Plc, Others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.